These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 35969277

  • 21. Hemolytic uremic syndrome in children.
    Talarico V, Aloe M, Monzani A, Miniero R, Bona G.
    Minerva Pediatr; 2016 Dec; 68(6):441-455. PubMed ID: 27768015
    [Abstract] [Full Text] [Related]

  • 22. Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome.
    Walsh PR, Johnson S.
    Pediatr Nephrol; 2019 Sep; 34(9):1485-1492. PubMed ID: 30058046
    [Abstract] [Full Text] [Related]

  • 23. Neurological involvement in children with hemolytic uremic syndrome.
    Costigan C, Raftery T, Carroll AG, Wildes D, Reynolds C, Cunney R, Dolan N, Drew RJ, Lynch BJ, O'Rourke DJ, Stack M, Sweeney C, Shahwan A, Twomey E, Waldron M, Riordan M, Awan A, Gorman KM.
    Eur J Pediatr; 2022 Feb; 181(2):501-512. PubMed ID: 34378062
    [Abstract] [Full Text] [Related]

  • 24. Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry.
    Kielstein JT, Beutel G, Fleig S, Steinhoff J, Meyer TN, Hafer C, Kuhlmann U, Bramstedt J, Panzer U, Vischedyk M, Busch V, Ries W, Mitzner S, Mees S, Stracke S, Nürnberger J, Gerke P, Wiesner M, Sucke B, Abu-Tair M, Kribben A, Klause N, Schindler R, Merkel F, Schnatter S, Dorresteijn EM, Samuelsson O, Brunkhorst R, Collaborators of the DGfN STEC-HUS registry.
    Nephrol Dial Transplant; 2012 Oct; 27(10):3807-15. PubMed ID: 23114903
    [Abstract] [Full Text] [Related]

  • 25. Severely ill pediatric patients with Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS) who suffered from multiple organ involvement in the early stage.
    Luna M, Kamariski M, Principi I, Bocanegra V, Vallés PG.
    Pediatr Nephrol; 2021 Jun; 36(6):1499-1509. PubMed ID: 33205220
    [Abstract] [Full Text] [Related]

  • 26. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
    Bruyand M, Mariani-Kurkdjian P, Gouali M, de Valk H, King LA, Le Hello S, Bonacorsi S, Loirat C.
    Med Mal Infect; 2018 May; 48(3):167-174. PubMed ID: 29054297
    [Abstract] [Full Text] [Related]

  • 27. HUS and the case for complement.
    Conway EM.
    Blood; 2015 Oct 29; 126(18):2085-90. PubMed ID: 26396094
    [Abstract] [Full Text] [Related]

  • 28. Comparative genomic analysis of a Shiga toxin-producing Escherichia coli (STEC) O145:H25 associated with a severe pediatric case of hemolytic uremic syndrome in Davidson County, Tennessee, US.
    Guerra JA, Zhang C, Bard JE, Yergeau D, Halasa N, Gómez-Duarte OG.
    BMC Genomics; 2020 Aug 17; 21(1):564. PubMed ID: 32807093
    [Abstract] [Full Text] [Related]

  • 29. Outbreak of hemolytic uremic syndrome with unusually severe clinical presentation caused by Shiga toxin-producing Escherichia coli O26:H11 in France.
    Minary K, Tanne C, Kwon T, Faudeux C, Clave S, Langevin L, Pietrement C, Enoch C, Parmentier C, Mariani-Kurkdjian P, Weill FX, Jones G, Djouadi N, Morin D, Fila M.
    Arch Pediatr; 2022 Aug 17; 29(6):448-452. PubMed ID: 35662540
    [Abstract] [Full Text] [Related]

  • 30. Complement Gene Variants and Shiga Toxin-Producing Escherichia coli-Associated Hemolytic Uremic Syndrome: Retrospective Genetic and Clinical Study.
    Frémeaux-Bacchi V, Sellier-Leclerc AL, Vieira-Martins P, Limou S, Kwon T, Lahoche A, Novo R, Llanas B, Nobili F, Roussey G, Cailliez M, Ulinski T, Deschênes G, Alberti C, Weill FX, Mariani P, Loirat C.
    Clin J Am Soc Nephrol; 2019 Mar 07; 14(3):364-377. PubMed ID: 30674459
    [Abstract] [Full Text] [Related]

  • 31. Hypertension and mild chronic kidney disease persist following severe haemolytic uraemic syndrome caused by Shiga toxin-producing Escherichia coli O104:H4 in adults.
    Derad I, Obermann B, Katalinic A, Eisemann N, Knobloch JK, Sayk F, Wellhöner P, Lehnert H, Solbach W, Süfke S, Steinhoff J, Nitschke M.
    Nephrol Dial Transplant; 2016 Jan 07; 31(1):95-103. PubMed ID: 26180049
    [Abstract] [Full Text] [Related]

  • 32. Bloody Diarrhea and Shiga Toxin-Producing Escherichia coli Hemolytic Uremic Syndrome in Children: Data from the ItalKid-HUS Network.
    Ardissino G, Vignati C, Masia C, Capone V, Colombo R, Tel F, Daprai L, Testa S, Dodaro A, Paglialonga F, Luini M, Brigotti M, Picicco D, Baldioli C, Pagani F, Ceruti R, Tommasi P, Possenti I, Cresseri D, Consonni D, Montini G, Arghittu M, ItalKid-HUS Network.
    J Pediatr; 2021 Oct 07; 237():34-40.e1. PubMed ID: 34197890
    [Abstract] [Full Text] [Related]

  • 33. Outbreak of Shiga toxin-producing Escherichia-coli-associated hemolytic uremic syndrome in Istanbul in 2015: outcome and experience with eculizumab.
    Ağbaş A, Göknar N, Akıncı N, Yıldırım ZY, Taşdemir M, Benzer M, Gökçe İ, Candan C, Küçük N, Uzuner S, Özçelik G, Demirkol D, Sever L, Çalışkan S.
    Pediatr Nephrol; 2018 Dec 07; 33(12):2371-2381. PubMed ID: 30159625
    [Abstract] [Full Text] [Related]

  • 34. Volume expansion mitigates Shiga toxin-producing E. coli-hemolytic uremic syndrome in children.
    Böckenhauer J, Schild R, Kemper MJ, Henne T, Stein MV, Oh J, Loos S.
    Pediatr Nephrol; 2024 Jun 07; 39(6):1901-1907. PubMed ID: 38240870
    [Abstract] [Full Text] [Related]

  • 35. STEC colitis mimicking acute severe colitis with life-threatening consequences: a case report.
    Hendrickx T, Peetermans M, D'Hoore A, Claes K, Van Hootegem A, Sabino J.
    Acta Gastroenterol Belg; 2024 Jun 07; 87(1):37-39. PubMed ID: 38431789
    [Abstract] [Full Text] [Related]

  • 36. Is Shigatoxin 1 protective for the development of Shigatoxin 2-related hemolytic uremic syndrome in children? Data from the ItalKid-HUS Network.
    Ardissino G, Possenti I, Vignati C, Daprai L, Capone V, Brigotti M, Luini MV, Consonni D, Montini G.
    Pediatr Nephrol; 2020 Oct 07; 35(10):1997-2001. PubMed ID: 32734345
    [Abstract] [Full Text] [Related]

  • 37. [Hemolytic uremic syndrome caused by Shiga-toxin-producing Escherichia coli].
    Loirat C.
    Rev Prat; 2013 Jan 07; 63(1):11-6. PubMed ID: 23457821
    [Abstract] [Full Text] [Related]

  • 38. Shiga toxin-producing Escherichia coli infection as a precipitating factor for atypical hemolytic-uremic syndrome.
    Mortari G, Bigatti C, Gaffi GP, Lionetti B, Angeletti A, Matarese S, Verrina EE, Caridi G, Lugani F, Vellone VG, Chiarenza DS, La Porta E.
    Pediatr Nephrol; 2024 Sep 30. PubMed ID: 39347991
    [Abstract] [Full Text] [Related]

  • 39. [Hemolytic uremic syndrome due to Shiga toxin–producing Escherichia coli and hypocomplementemia with favorable response to eculizumab: a case report].
    Balestracci A, Meni Battaglia L, Martin SM, Toledo I, Puyol I, Beaudoin L, Robledo NL.
    Rev Fac Cien Med Univ Nac Cordoba; 2021 Jun 28; 78(2):188-192. PubMed ID: 34181840
    [Abstract] [Full Text] [Related]

  • 40. Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome.
    Westra D, Volokhina EB, van der Molen RG, van der Velden TJ, Jeronimus-Klaasen A, Goertz J, Gracchi V, Dorresteijn EM, Bouts AH, Keijzer-Veen MG, van Wijk JA, Bakker JA, Roos A, van den Heuvel LP, van de Kar NC.
    Pediatr Nephrol; 2017 Feb 28; 32(2):297-309. PubMed ID: 27718086
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.